Trospium Chloride
Trospium Chloride market is segmented by region (country), players, by Type and by Application. P ... Read More
Global and United States Rifaximin Market Report & Forecast 2024-2031
1 Study Coverage
1.1 Rifaximin Product Introduction
1.2 Global Rifaximin Outlook 2017 VS 2022 VS 2028
1.2.1 Global Rifaximin Sales in US$ Million for the Year 2017-2028
1.2.2 Global Rifaximin Sales in Volume for the Year 2017-2028
1.3 United States Rifaximin Outlook 2017 VS 2022 VS 2028
1.3.1 United States Rifaximin Sales in US$ Million for the Year 2017-2028
1.3.2 United States Rifaximin Sales in Volume for the Year 2017-2028
1.4 Rifaximin Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Rifaximin in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Rifaximin Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Rifaximin Market Dynamics
1.5.1 Rifaximin Industry Trends
1.5.2 Rifaximin Market Drivers
1.5.3 Rifaximin Market Challenges
1.5.4 Rifaximin Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Rifaximin Market Segment by Type
2.1.1 200 mg Tablets
2.1.2 550 mg Tablets
2.2 Global Rifaximin Market Size by Type
2.2.1 Global Rifaximin Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Rifaximin Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Rifaximin Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Rifaximin Market Size by Type
2.3.1 United States Rifaximin Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Rifaximin Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Rifaximin Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Rifaximin Market Segment by Application
3.1.1 Hospital
3.1.2 Drug store
3.2 Global Rifaximin Market Size by Application
3.2.1 Global Rifaximin Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Rifaximin Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Rifaximin Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Rifaximin Market Size by Application
3.3.1 United States Rifaximin Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Rifaximin Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Rifaximin Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Rifaximin Competitor Landscape by Company
4.1 Global Rifaximin Market Size by Company
4.1.1 Top Global Rifaximin Manufacturers Ranked by Revenue (2021)
4.1.2 Global Rifaximin Revenue by Manufacturer (2017-2022)
4.1.3 Global Rifaximin Sales by Manufacturer (2017-2022)
4.1.4 Global Rifaximin Price by Manufacturer (2017-2022)
4.2 Global Rifaximin Concentration Ratio (CR)
4.2.1 Rifaximin Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Rifaximin in 2021
4.2.3 Global Rifaximin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Rifaximin Manufacturing Base Distribution, Product Type
4.3.1 Global Rifaximin Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Rifaximin Product Type
4.3.3 Date of International Manufacturers Enter into Rifaximin Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Rifaximin Market Size by Company
4.5.1 Top Rifaximin Players in United States, Ranked by Revenue (2021)
4.5.2 United States Rifaximin Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Rifaximin Sales by Players (2020, 2021 & 2022)
5 Global Rifaximin Market Size by Region
5.1 Global Rifaximin Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Rifaximin Market Size in Volume by Region (2017-2028)
5.2.1 Global Rifaximin Sales in Volume by Region: 2017-2022
5.2.2 Global Rifaximin Sales in Volume Forecast by Region (2023-2028)
5.3 Global Rifaximin Market Size in Value by Region (2017-2028)
5.3.1 Global Rifaximin Sales in Value by Region: 2017-2022
5.3.2 Global Rifaximin Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Rifaximin Market Size YoY Growth 2017-2028
6.1.2 North America Rifaximin Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Rifaximin Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Rifaximin Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Rifaximin Market Size YoY Growth 2017-2028
6.3.2 Europe Rifaximin Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Rifaximin Market Size YoY Growth 2017-2028
6.4.2 Latin America Rifaximin Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Rifaximin Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Rifaximin Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 Salix Pharmaceuticals
7.1.1 Salix Pharmaceuticals Corporation Information
7.1.2 Salix Pharmaceuticals Description and Business Overview
7.1.3 Salix Pharmaceuticals Rifaximin Sales, Revenue and Gross Margin (2017-2022)
7.1.4 Salix Pharmaceuticals Rifaximin Products Offered
7.1.5 Salix Pharmaceuticals Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Rifaximin Industry Chain Analysis
8.2 Rifaximin Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Rifaximin Distributors
8.3 Rifaximin Production Mode & Process
8.4 Rifaximin Sales and Marketing
8.4.1 Rifaximin Sales Channels
8.4.2 Rifaximin Distributors
8.5 Rifaximin Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Rifaximin CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
Table 2. Rifaximin Market Trends
Table 3. Rifaximin Market Drivers
Table 4. Rifaximin Market Challenges
Table 5. Rifaximin Market Restraints
Table 6. Global Rifaximin Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Rifaximin Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Rifaximin Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Rifaximin Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Rifaximin Manufacturers in Global Market, Ranking by Revenue (2021)
Table 11. Global Rifaximin Revenue by Manufacturer, (US$ Million), 2017-2022
Table 12. Global Rifaximin Revenue Share by Manufacturer, 2017-2022
Table 13. Global Rifaximin Sales by Manufacturer, (K Units), 2017-2022
Table 14. Global Rifaximin Sales Share by Manufacturer, 2017-2022
Table 15. Global Rifaximin Price by Manufacturer (2017-2022) & (USD/Unit)
Table 16. Global Rifaximin Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Rifaximin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rifaximin as of 2021)
Table 18. Top Players of Rifaximin in Global Market, Headquarters and Distribution of Producing Region
Table 19. Manufacturers Rifaximin Product Type
Table 20. Date of International Manufacturers Enter into Rifaximin Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Top Rifaximin Players in United States Market, Ranking by Revenue (2021)
Table 23. United States Rifaximin Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 24. United States Rifaximin Revenue Share by Players, 2020, 2021 & 2022
Table 25. United States Rifaximin Sales by Players, (K Units), 2020, 2021 & 2022
Table 26. United States Rifaximin Sales Share by Players, 2020, 2021 & 2022
Table 27. Global Rifaximin Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 28. Global Rifaximin Sales in Volume by Region (2017-2022) & (K Units)
Table 29. Global Rifaximin Sales in Volume Forecast by Region (2023-2028) & (K Units)
Table 30. Global Rifaximin Sales in Value by Region (2017-2022) & (US$ Million)
Table 31. Global Rifaximin Sales in Value Forecast by Region (2023-2028) & (US$ Million)
Table 32. North America Rifaximin Sales in Volume by Country (2017-2028) & (K Units)
Table 33. North America Rifaximin Sales in Value by Country (2017-2028) & (US$ Million)
Table 34. Asia Pacific Rifaximin Sales in Volume by Region (2017-2028) & (K Units)
Table 35. Asia Pacific Rifaximin Sales in Value by Region (2017-2028) & (US$ Million)
Table 36. Europe Rifaximin Sales in Volume by Country (2017-2028) & (K Units)
Table 37. Europe Rifaximin Sales in Value by Country (2017-2028) & (US$ Million)
Table 38. Latin America Rifaximin Sales in Volume by Country (2017-2028) & (K Units)
Table 39. Latin Americaa Rifaximin Sales in Value by Country (2017-2028) & (US$ Million)
Table 40. Middle East and Africa Rifaximin Sales in Volume by Country (2017-2028) & (K Units)
Table 41. Middle East and Africa Rifaximin Sales in Value by Country (2017-2028) & (US$ Million)
Table 42. Salix Pharmaceuticals Corporation Information
Table 43. Salix Pharmaceuticals Description and Business Overview
Table 44. Salix Pharmaceuticals Rifaximin Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 45. Salix Pharmaceuticals Rifaximin Product
Table 46. Salix Pharmaceuticals Recent Development
Table 47. Key Raw Materials Lists
Table 48. Raw Materials Key Suppliers Lists
Table 49. Rifaximin Customers List
Table 50. Rifaximin Distributors List
Table 51. Research Programs/Design for This Report
Table 52. Key Data Information from Secondary Sources
Table 53. Key Data Information from Primary Sources
List of Figures
Figure 1. Rifaximin Product Picture
Figure 2. Global Rifaximin Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Rifaximin Market Size 2017-2028 (US$ Million)
Figure 4. Global Rifaximin Sales 2017-2028 (K Units)
Figure 5. United States Rifaximin Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 6. United States Rifaximin Market Size 2017-2028 (US$ Million)
Figure 7. United States Rifaximin Sales 2017-2028 (K Units)
Figure 8. United States Rifaximin Market Share in Global, in Value (US$ Million) 2017-2028
Figure 9. United States Rifaximin Market Share in Global, in Volume (K Units) 2017-2028
Figure 10. Rifaximin Report Years Considered
Figure 11. Product Picture of 200 mg Tablets
Figure 12. Product Picture of 550 mg Tablets
Figure 13. Global Rifaximin Market Share by Type in 2022 & 2028
Figure 14. Global Rifaximin Sales in Value by Type (2017-2028) & (US$ Million)
Figure 15. Global Rifaximin Sales Market Share in Value by Type (2017-2028)
Figure 16. Global Rifaximin Sales by Type (2017-2028) & (K Units)
Figure 17. Global Rifaximin Sales Market Share in Volume by Type (2017-2028)
Figure 18. Global Rifaximin Price by Type (2017-2028) & (USD/Unit)
Figure 19. United States Rifaximin Market Share by Type in 2022 & 2028
Figure 20. United States Rifaximin Sales in Value by Type (2017-2028) & (US$ Million)
Figure 21. United States Rifaximin Sales Market Share in Value by Type (2017-2028)
Figure 22. United States Rifaximin Sales by Type (2017-2028) & (K Units)
Figure 23. United States Rifaximin Sales Market Share in Volume by Type (2017-2028)
Figure 24. United States Rifaximin Price by Type (2017-2028) & (USD/Unit)
Figure 25. Product Picture of Hospital
Figure 26. Product Picture of Drug store
Figure 27. Global Rifaximin Market Share by Application in 2022 & 2028
Figure 28. Global Rifaximin Sales in Value by Application (2017-2028) & (US$ Million)
Figure 29. Global Rifaximin Sales Market Share in Value by Application (2017-2028)
Figure 30. Global Rifaximin Sales by Application (2017-2028) & (K Units)
Figure 31. Global Rifaximin Sales Market Share in Volume by Application (2017-2028)
Figure 32. Global Rifaximin Price by Application (2017-2028) & (USD/Unit)
Figure 33. United States Rifaximin Market Share by Application in 2022 & 2028
Figure 34. United States Rifaximin Sales in Value by Application (2017-2028) & (US$ Million)
Figure 35. United States Rifaximin Sales Market Share in Value by Application (2017-2028)
Figure 36. United States Rifaximin Sales by Application (2017-2028) & (K Units)
Figure 37. United States Rifaximin Sales Market Share in Volume by Application (2017-2028)
Figure 38. United States Rifaximin Price by Application (2017-2028) & (USD/Unit)
Figure 39. North America Rifaximin Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 40. North America Rifaximin Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 41. U.S. Rifaximin Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 42. Canada Rifaximin Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 43. Europe Rifaximin Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 44. Europe Rifaximin Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 45. Germany Rifaximin Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 46. France Rifaximin Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 47. U.K. Rifaximin Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 48. Italy Rifaximin Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 49. Russia Rifaximin Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 50. Asia-Pacific Rifaximin Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 51. Asia-Pacific Rifaximin Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 52. China Rifaximin Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 53. Japan Rifaximin Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 54. South Korea Rifaximin Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 55. India Rifaximin Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 56. Australia Rifaximin Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 57. Taiwan Rifaximin Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 58. Indonesia Rifaximin Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 59. Thailand Rifaximin Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 60. Malaysia Rifaximin Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 61. Philippines Rifaximin Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 62. Latin America Rifaximin Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 63. Latin America Rifaximin Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 64. Mexico Rifaximin Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 65. Brazil Rifaximin Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 66. Argentina Rifaximin Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 67. Middle East & Africa Rifaximin Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 68. Middle East & Africa Rifaximin Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 69. Turkey Rifaximin Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 70. Saudi Arabia Rifaximin Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 71. U.A.E Rifaximin Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 72. Rifaximin Value Chain
Figure 73. Rifaximin Production Process
Figure 74. Channels of Distribution
Figure 75. Distributors Profiles
Figure 76. Bottom-up and Top-down Approaches for This Report
Figure 77. Data Triangulation
Figure 78. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Salix Pharmaceuticals